An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
Condition: HypertensionInterventions: Drug: Aliskiren; Drug: EnalaprilSponsors: Novartis; Novartis PharmaceuticalsRecruiting - verified July 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials